Found: 16
Select item for more details and to access through your institution.
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 4, p. 583, doi. 10.3390/jpm13040583
- By:
- Publication type:
- Article
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 4, p. 707, doi. 10.1093/cid/ciab492
- By:
- Publication type:
- Article
SARS-CoV-2 infection in patients with primary central nervous system lymphoma.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 9, p. 3072, doi. 10.1007/s00415-020-10311-w
- By:
- Publication type:
- Article
EPIDEMIOLOGICAL AND MOLECULAR EVOLUTION OF THE HIV-1 CRF94: BIRTH OF CRF132.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 337
- By:
- Publication type:
- Article
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 7, p. 1673, doi. 10.1093/jac/dkae164
- By:
- Publication type:
- Article
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 7, p. 1706, doi. 10.1093/jac/dkae115
- By:
- Publication type:
- Article
Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 8, p. 1929, doi. 10.1093/jac/dkad185
- By:
- Publication type:
- Article
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1510, doi. 10.1093/jac/dkad119
- By:
- Publication type:
- Article
More HIV-1 RNA detected and quantified with the Cobas 6800 system in patients on antiretroviral therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.
- Published in:
- 2020
- By:
- Publication type:
- journal article